Should tesamorelin be cycled?

Its own FDA label answers this directly: tesamorelin (Egrifta) is approved as a daily injection taken continuously for as long as treatment for HIV-associated visceral fat is indicated, with no cycling schedule in the approved regimen, despite tesamorelin being a GHRH analogue in the same receptor family discussed above.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of cycling and clearance. Whether peptides need a break, what a half-life actually tells you, and where a real cycling mechanism has been measured. Full detail at /cycling.